Otto Schwarz, PhD, is the former COO of Actelion Pharmaceuticals Ltd (2008-2017). He is a pharmacist with a PhD from the University of Vienna and was a post-doc at the University of Florida. Currently, he is Managing Director of Concentus Consulting, Switzerland. Prior to Actelion, he was Executive Board Member of Altana Pharma, Germany (2004-2008) and before that spent 16 years at Schering-Plough and 4 years at Eli Lilly. He is currently on the board of privately held Stalicla, Lausanne, and has been a board member of Kiadis Pharma AB/Netherlands and Chairman of the Board of Arvelle Therapeutics/Netherlands until the sale of both companies in 2021. He also served for 3 years as member of the foundation board of the MAX7 Foundation/Germany. Since July 1, 2023, Otto Schwarz, PhD, acts as an advisor to the management of Idorsia Pharmaceuticals Ltd, Santhera's largest shareholder.

At Santhera, Otto Schwarz, PhD, serves as Board member since the AGM 2023.